These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 14524654

  • 1. From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy.
    Fuller DE, Hornfeldt CS.
    Pharmacotherapy; 2003 Sep; 23(9):1205-9. PubMed ID: 14524654
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Xyrem approved for muscle problems in narcolepsy.
    FDA Consum; 2002 Sep; 36(5):7. PubMed ID: 12412541
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The clinical development of gamma-hydroxybutyrate (GHB).
    Wedin GP, Hornfeldt CS, Ylitalo LM.
    Curr Drug Saf; 2006 Jan; 1(1):99-106. PubMed ID: 18690919
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Xyrem: date-rape drug approved for cataplexy.
    Nursing; 2002 Oct; 32(10):24. PubMed ID: 12400573
    [No Abstract] [Full Text] [Related]

  • 9. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ.
    Rev Neurol; 2002 Oct; 48(1):27-31. PubMed ID: 19145563
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sodium oxybate for cataplexy.
    Lemon MD, Strain JD, Farver DK.
    Ann Pharmacother; 2006 Mar; 40(3):433-40; quiz 581-2. PubMed ID: 16507620
    [Abstract] [Full Text] [Related]

  • 12. Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse.
    Carter LP, Pardi D, Gorsline J, Griffiths RR.
    Drug Alcohol Depend; 2009 Sep 01; 104(1-2):1-10. PubMed ID: 19493637
    [Abstract] [Full Text] [Related]

  • 13. Sodium oxybate and sleep apnea: a clinical case.
    Hartley S, Quera-Salva MA, Machou M.
    J Clin Sleep Med; 2011 Dec 15; 7(6):667-8. PubMed ID: 22171208
    [Abstract] [Full Text] [Related]

  • 14. Sodium oxybate for narcolepsy.
    Scharf MB.
    Expert Rev Neurother; 2006 Aug 15; 6(8):1139-46. PubMed ID: 16893342
    [Abstract] [Full Text] [Related]

  • 15. Xyrem (sodium oxybate) postmarketing adverse event reporting system.
    Wang YG.
    Sleep Med; 2010 Jun 15; 11(6):595; author reply 595-6. PubMed ID: 20362501
    [No Abstract] [Full Text] [Related]

  • 16. Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion.
    Wang YG, Swick TJ, Carter LP, Thorpy MJ, Benowitz NL.
    J Clin Sleep Med; 2009 Aug 15; 5(4):365-71. PubMed ID: 19968016
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness and optimization of low-sodium oxybate in participants with narcolepsy switching from a high-sodium oxybate: data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav study.
    Macfadden W, Leary EB, Fuller DS, Kirby MT, Roy A.
    J Clin Sleep Med; 2024 Sep 01; 20(9):1467-1477. PubMed ID: 38652499
    [Abstract] [Full Text] [Related]

  • 18. Sodium oxybate: a review of its use in the management of narcolepsy.
    Robinson DM, Keating GM.
    CNS Drugs; 2007 Sep 01; 21(4):337-54. PubMed ID: 17381187
    [Abstract] [Full Text] [Related]

  • 19. Narcolepsy: treatment issues.
    Roth T.
    J Clin Psychiatry; 2007 Sep 01; 68 Suppl 13():16-9. PubMed ID: 18078361
    [Abstract] [Full Text] [Related]

  • 20. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
    Busardò FP, Kyriakou C, Napoletano S, Marinelli E, Zaami S.
    Eur Rev Med Pharmacol Sci; 2015 Dec 01; 19(23):4654-63. PubMed ID: 26698265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.